[引用][C] Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.

A Levi, Y Tal, Z Dranitzki, M Shalit… - Pediatric Allergy & …, 2015 - search.ebscohost.com
A Levi, Y Tal, Z Dranitzki, M Shalit, CD Enk
Pediatric Allergy & Immunology, 2015search.ebscohost.com
… To our knowledge, this is the first report of successful and safe use of omalizumab in
children <12 years of age for CSU and the first report of successful treatment of delayed
pressure urticaria in children. Our small case series demonstrates that omalizumab is very
effective in CSU patients with normal CD63 levels and that high CD63 expression level may
indicate more persistent forms that may require more frequent injections or higher dosage.
Larger studies are required to establish the role of CD63 expression as a potential marker …
Abstract
A letter to the editor is presented in response to the article" Physical urticaria," by JP Dice in the 2004 issue.
search.ebscohost.com
以上显示的是最相近的搜索结果。 查看全部搜索结果

Google学术搜索按钮

example.edu/paper.pdf
搜索
获取 PDF 文件
引用
References